Pregnancy rates and outcomes in early axial spondyloarthritis: An analysis of the DESIR cohort.


Journal

Joint bone spine
ISSN: 1778-7254
Titre abrégé: Joint Bone Spine
Pays: France
ID NLM: 100938016

Informations de publication

Date de publication:
Mar 2021
Historique:
received: 20 05 2020
accepted: 02 09 2020
pubmed: 19 9 2020
medline: 29 6 2021
entrez: 18 9 2020
Statut: ppublish

Résumé

Only scarce data is available regarding pregnancy outcomes in early axSpA, particularly little is known about the impact of disease activity. The objective is to identify (a) the factors associated with the occurrence of a clinical pregnancy during follow-up and (b) the risk factors for an unfavorable pregnancy outcome (e.g. miscarriage, medical termination or pre-term delivery) in an early axSpA population. Observational prospective French cohort (DESIR) with 6 years of follow-up including 381 TNFi-naïve women with early axSpA. Factors associated with a clinical pregnancy occurring over follow-up and risk factors for an unfavorable pregnancy outcome were estimated by multivariable multilevel models (i.e. Frailty Shared Models and Mixed Models). During follow-up, 124 pregnancies occurred. Patients who got pregnant during follow-up were more likely to have discontinued their TNFi treatment in the 6 months preceding the pregnancy (HR=2.0 [95% CI 1.1-3.3], P=0.01) and to have an increased CRP at the previous visit (HR=1.7 [95% CI 1.2-2.5], P=0.01). Full-term delivery was by far the most frequent pregnancy outcome (75% of all pregnancies), and only NSAID use in the 6 months prior to the outcome was associated with an unfavorable outcome (OR=2.5 [95% CI 1.1-5.0], P=0.02). No association was found between TNFi use and an unfavorable pregnancy outcome. Full-term delivery was the most frequent pregnancy outcome. NSAID use within 6 months of outcome, but not TNFi use, was associated with an unfavorable pregnancy outcome in this early axSpA cohort.

Identifiants

pubmed: 32947013
pii: S1297-319X(20)30160-3
doi: 10.1016/j.jbspin.2020.09.007
pii:
doi:

Substances chimiques

Tumor Necrosis Factor-alpha 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

105075

Informations de copyright

Copyright © 2020 Société française de rhumatologie. Published by Elsevier Masson SAS. All rights reserved.

Auteurs

Marion Pons (M)

Rheumatology department, Cochin Hospital, Paris, France; INSERM U-1153, Center for Epidemiology and Statistics Sorbonne Paris Cité (CRESS), Paris-Sorbonne, Paris, France. Electronic address: msenlis@hotmail.com.

Maxime Dougados (M)

Rheumatology department, Cochin Hospital, Paris, France; INSERM U-1153, Center for Epidemiology and Statistics Sorbonne Paris Cité (CRESS), Paris-Sorbonne, Paris, France.

Nathalie Costedoat-Chalumeau (N)

INSERM U-1153, Center for Epidemiology and Statistics Sorbonne Paris Cité (CRESS), Paris-Sorbonne, Paris, France; AP-HP, Cochin Hospital, Internal Medicine Department, Referral center for rare autoimmune and systemic diseases, Paris, France; Paris Descartes-Sorbonne Paris Cité University, Paris, France.

Karine Briot (K)

Rheumatology department, Cochin Hospital, Paris, France; INSERM U-1153, Center for Epidemiology and Statistics Sorbonne Paris Cité (CRESS), Paris-Sorbonne, Paris, France.

Philippe Goupille (P)

University hospital of Tours, Rheumatology department, Tours, France; University of Tours, EA 7501 GICC, Tours, France.

Christian Roux (C)

Rheumatology department, Cochin Hospital, Paris, France; INSERM U-1153, Center for Epidemiology and Statistics Sorbonne Paris Cité (CRESS), Paris-Sorbonne, Paris, France.

Anna Molto (A)

Rheumatology department, Cochin Hospital, Paris, France; INSERM U-1153, Center for Epidemiology and Statistics Sorbonne Paris Cité (CRESS), Paris-Sorbonne, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH